These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 6815638)

  • 1. [Thyroliberin and its importance in thyroid diseases].
    Vakulenko AD
    Probl Endokrinol (Mosk); 1982; 28(5):82-7. PubMed ID: 6815638
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical use of synthetic thyroliberin (thyrotropin-releasing factor)].
    Starkova NT; Ktova GA; Aleksandrova GF; Mel'nichenko GA; Matveeva LS
    Probl Endokrinol (Mosk); 1978; 24(5):103-10. PubMed ID: 100777
    [No Abstract]   [Full Text] [Related]  

  • 3. Diseases of the thyroid gland.
    Ladenson PW
    Clin Endocrinol Metab; 1985 Feb; 14(1):145-73. PubMed ID: 2861924
    [No Abstract]   [Full Text] [Related]  

  • 4. [Serum prolactin fluctuation caused by TRH tolerance test in thyroid disorders].
    Inoue K; Enomoto K; Irie M
    Horumon To Rinsho; 1974 Apr; 22(4):519-23. PubMed ID: 4214487
    [No Abstract]   [Full Text] [Related]  

  • 5. [Exploration of the hypothalamo-hypophyseal-thyroid axis in children].
    Chaussain JL; Binet E; Vassal J; Job JC
    Arch Fr Pediatr; 1974; 31(6):575-86. PubMed ID: 4216339
    [No Abstract]   [Full Text] [Related]  

  • 6. [Interrelation of thyroid hormones and prolactin].
    Gladkova AI
    Probl Endokrinol (Mosk); 1984; 30(3):79-89. PubMed ID: 6429661
    [No Abstract]   [Full Text] [Related]  

  • 7. Thyroid function tests in thyroid and nonthyroid disease.
    Trainer TD; Howard PL
    Crit Rev Clin Lab Sci; 1983; 19(2):135-71. PubMed ID: 6426859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Value of the test using TRH in the exploration of thyroid diseases].
    Demeester-Mirkine N; Bossuyt A; Brauman H; Corvilain J
    Nouv Presse Med; 1975 Apr; 4(15):1125-9. PubMed ID: 49040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prolactin level in thyroid diseases and its reaction to thyroliberin].
    Vakulenko AD; Niiazova ZhM; Simakova GM
    Probl Endokrinol (Mosk); 1981; 27(4):6-10. PubMed ID: 6794025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of oral TRH on the thyroid function, thyrotropin and prolactin secretion, in 9 normal subjects].
    Slama G; Luton JP; Canivet B; Strauch G; Jourde B; Meyniel M; Bricaire H
    Ann Endocrinol (Paris); 1974; 35(5):587-90. PubMed ID: 4219113
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects on the pituitary-thyroid axis and prolactin secretion of single and repetitive oral doses of thyrotropin-releasing hormone (TRH).
    Rabello MM; Snyder PJ; Utiger RD
    J Clin Endocrinol Metab; 1974 Sep; 39(3):571-8. PubMed ID: 4213076
    [No Abstract]   [Full Text] [Related]  

  • 12. Oral administration of thyrotropin-releasing hormone (TRH) in the diagnosis of thyreopathies.
    Felt V; Nedvídková J
    Czech Med; 1978; 1(3):162-8. PubMed ID: 100297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison between TRH-stimulated TSH and basal TSH measurement by a commercial immunoradiometric assay in the management of thyroid disease.
    De Rosa G; Testa A; Giacomini D; Carrozza C; Maussier ML; Valenza V; D'Errico GF
    Q J Nucl Med; 1996 Jun; 40(2):182-7. PubMed ID: 8909104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [New aspects of thyroid gland diagnostics].
    zur Mühlen A von ; Hesch RD; Köbberling J
    Dtsch Med Wochenschr; 1974 Jul; 99(28):1504-5. PubMed ID: 4137441
    [No Abstract]   [Full Text] [Related]  

  • 15. Sexual impotence: studies of the hypothalamic-pituitary-thyroid axis and the effect of oral thyrotropin-releasing factor.
    Benkert O; Horn K; Pickardt CR; Schmid D
    Arch Sex Behav; 1976 Jul; 5(4):269-74. PubMed ID: 182105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolactin and thyrotropin in thyroid diseases: lack of evidence for a physiological role of thyrotropin-releasing hormone in the regulation of prolactin secretion.
    L'Hermite M; Robyn C; Golstein J; Rothenbuchner G; Birk J; Loos U; Bonnyns M; Vanhaelst L
    Horm Metab Res; 1974 May; 6(3):190-5. PubMed ID: 4209662
    [No Abstract]   [Full Text] [Related]  

  • 17. [Possibilities in the use of synthetic "thyrotropin releasing factor" (TRF) in the functional diagnosis of thyroid gland diseases].
    zur Mühlen A von ; Hesch RD; Emrich D; Köbberling J
    Verh Dtsch Ges Inn Med; 1971; 77():655-7. PubMed ID: 5005537
    [No Abstract]   [Full Text] [Related]  

  • 18. Pituitary-thyroid responsiveness to intramuscular thyrotropin-releasing hormone based on analyses of serum thyroxine, tri-iodothyronine and thyrotropin concentrations.
    Azizi F; Vagenakis AG; Portnay GI; Rapoport B; Ingbar SH; Braverman LE
    N Engl J Med; 1975 Feb; 292(6):273-7. PubMed ID: 803298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subclinical thyroid disease: consensus or conundrum?
    Cooper DS
    Clin Endocrinol (Oxf); 2004 Apr; 60(4):410-2. PubMed ID: 15049953
    [No Abstract]   [Full Text] [Related]  

  • 20. The effect of metformin on the hypothalamic-pituitary-thyroid axis in patients with type 2 diabetes and amiodarone-induced hypothyroidism.
    Krysiak R; Gilowska M; Szkróbka W; Okopień B
    Pharmacol Rep; 2016 Apr; 68(2):490-4. PubMed ID: 26922558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.